Ali Tehrani is a venture partner at Amplitude Ventures. He is a co-founder of Zymeworks Inc. and served as president and CEO from the company’s inception in September 2003 to January 2022. Tehrani is a board member of BIOTECanada, Creatus Biosciences and Nanology Labs, and a member of Canada’s COVID-19 Therapeutics Task Force.
GREATEST SUCCESS: Growing Zymeworks to a Phase 3 clinical stage company.
GOAL FOR 2022: Give back more than I take.
BIGGEST LESSON: Every day ask yourself: What should I be doing that I am not?
FAVOURITE QUOTE: “It is OK to make mistakes, but not OK to make the same mistake twice.”